N@N

50.64% Of All NASDAQ Trading Tuesday Was Short Selling. DEER, PSTI, PVSW, ENCO, STBA, PCBC Highest % Of Daily Trading Volume S

^{Published on 2009-10-20 15:20:18, Last Modified on 2010-12-22 17:19:19 - WOPRAI}
 

October 21, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Tuesday, October 20th, 2009 and come to the following statistical conclusions. There were 6,826 stocks with daily short volume reported and total NASDAQ trading volume of 1,840,523,430 shares. Total Daily Short Volume was 932,111,316 shares. 50.64% of all trading on the NASDAQ Tuesday was short selling. The chart below highlights 6 stocks that had unusually high percentages of their total daily trading volume attributed to short sales. Deer Consumer Products (NASDAQ: DEER), Pluristem Therapeutics (NASDAQ: PSTI), Pervasive Software (NASDAQ: PVSW), Encorium Group (NASDAQ: ENCO), S and T Bancorp (NASDAQ: STBA) and Pacific Capital Bancorp (NASDAQ: PCBC). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

DATE SYMBOL SHORT VOLUME TOTAL VOLUME MARKET PERCENT

20091020 DEER 63,388 68,788 Q 92.15%

20091020 PSTI 34,000 37,304 Q 91.14%

20091020 PVSW 97,436 109,336 Q 89.12%

20091020 ENCO 156,980 182,390 Q 86.07%

20091020 STBA 105,651 126,579 Q 83.47%

20091020 PCBC 177,459 223,807 Q 79.29%

In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesa� naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales.

Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities.

The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted.

Deer Consumer Products, Inc. (NASDAQ: DEER), through its subsidiaries, engages in the design, manufacture, and sale of home and kitchen electronic appliances. Its products include blenders and juice extractors, soymilk makers, popcorn makers, meat grinders, rice cookers, electric water kettles, pressure cookers, and other food processors. The company offers its products to original design manufacturers, original brand manufacturers, and original equipment manufacturers worldwide. Deer Consumer Products, Inc. is based in Shenzhen, China.

Pluristem Therapeutics Inc. (NASDAQ: PSTI), a development stage bio-therapeutics company, engages in the research, development, and production of placental-derived adherent stromal cells (ASCs). The company also involves in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of various severe degenerative, ischemic, and autoimmune disorders. It develops a pipeline of products that are derived from the human placenta, a non-controversial, non-embryonic, and adult stem cell source. These placental adherent stromal cells (ASCs) are expanded in the companya�s proprietary PluriX three-dimensional bioreactor, which imitates the natural microstructure of bone marrow and does not require supplemental growth factors or other exogenous materials. The companya�s principal product under Phase I clinical trial is PLX-PAD for people suffering from peripheral artery disease. Its pre-clinical products include PLX-IBD for inflammatory bowel diseases; PLX-STROKE for ischemic strokes; PLX-BMT for bone marrow transplantation; and PLX-MS for multiple sclerosis. The company was formerly known as Pluristem Life Systems Inc. and changed its name to Pluristem Therapeutics Inc. in November 2007. Pluristem Therapeutics Inc. was founded in 2001 and is based in Haifa, Israel.

Pervasive Software, Inc. (NASDAQ: PVSW) develops, markets, sells, and supports embeddable data management and integration software products worldwide. Its solutions enable customers to manage, integrate, secure, and analyze their data. The companya�s data management product line includes Pervasive PSQL, a database product offering for client/server applications deployed on various operating systems and access methods; Pervasive DataExchange, which features targeted solutions to data movement and synchronization problems; Pervasive Backup Agent, a backup solution; and Pervasive AuditMaster that monitors and reports activity occurring in a Pervasive PSQL database. Its data and application integration product line comprises Pervasive Data Integrator, which aggregates and integrates data; Pervasive Data Profiler that reduces the complexities, risk, and expense associated with manually checking data; and Pervasive Data MatchMerge for identification of data redundancies and data quality issues, such as duplicates; Pervasive Integration Hub, which provides a solution to a common integration scenario; Pervasive Metadata Manager, a metadata warehouse solution; and Pervasive Integration Manager, a browser-based management console, which provides single-point administration, performance monitoring, integration engine deployment, and job scheduling of integration processes running on remote integration engines. The company also offers Pervasive WebDI that provides supply-chain management and internal and external data exchange and integration functionality; Pervasive DataSolutions, which offers customers and partners with data services-based integration; and Pervasive DataRush that is designed to capture the parallel processing capabilities of multi-core technologies. Pervasive Software, Inc. was founded in 1994 and is headquartered in Austin, Texas with additional offices in Greenville, South Carolina; Brussels, Belgium; Frankfurt, Germany; Paris, France; and London, the United Kingdom.

Encorium Group, Inc. (NASDAQ: ENCO) designs and manages clinical trials for pharmaceutical, biotechnology, and medical device industries primarily in Europe. The companya�s clinical research and development services supporting Phase I through Phase IV clinical trials include data management, such as CRF review and tracking, data entry, clinical/statistical reports, and writing manuscripts for publication; and biostatistics for the use of professionals to develop and review protocols, design analysis plans, and report formats in various phases of drug development. Its services also include strategic trial planning; project management; medical writing; quality assurance and compliance, such as investigator audits, pre-submission protocol compliance audits, and GCP audits; outsourcing clinical staff; and clinical trials management comprising case report form design, investigator recruitment, patient enrollment, and study monitoring and data collection. In addition, Encoriuma�s services include study protocol design; medical and regulatory affairs, such as regulatory strategy formulation, new drug and biologic license application document preparation and review, and quality assurance and liaison; pharmacovigilance; compliance and medical report writing; patient registries; and medical device certification. It also licenses Oracle Clinical and Datafax as its clinical trials management systems. Encorium offers clinical trial services in various therapeutic areas, such as cardiovascular, nephrology, endocrinology/metabolism, hematology, diabetes, neurology, oncology, immunology, vaccines, infectious diseases, gastroenterology, dermatology, hepatology, rheumatology, urology, ophthalmology, womena�s health, and respiratory medicine. It was formerly known as Covalent Group, Inc. and changed its name to Encorium Group, Inc. in October 2006 in connection with the acquisition of Remedium Oy. The company was founded in 1989 and is headquartered in Wayne, Pennsylvania.

S and T Bancorp, Inc. (NASDAQ: STBA) operates as the holding company for the S&T Bank, which provides community banking services to individual and corporate customers in Pennsylvania. The company offers noninterest-bearing demand accounts, NOW/money market accounts, savings accounts, and time deposit accounts. Its lending products include real estate construction and commercial loans consisting of mortgage and industrial loans. The company also provides letters of credit, discount brokerage services, personal financial planning, and credit card services. S&T Bancorp, Inc., through its nonbanking subsidiaries, acts as a reinsurer of credit life, accident, and health insurance policies; distributes commercial property and casualty insurance, as well as provides group life and health coverage, employee benefit solutions, and personal insurance lines; and manages private investment accounts for individuals and institutions. The company also provides cash management services, financial and estate planning, estate and trust administration, investment management, employee benefit services and administration, corporate services, and other fiduciary services. As of April 20, 2009, it had 55 offices within Allegheny, Armstrong, Blair, Butler, Cambria, Clarion, Clearfield, Indiana, Jefferson, and Westmoreland counties of Pennsylvania. The company was founded in 1983 and is headquartered in Indiana, Pennsylvania.

Pacific Capital Bancorp (NASDAQ: PCBC) operates as the holding company for Pacific Capital Bank, N.A., which provides a range of commercial and consumer banking services to households, professionals, and businesses primarily in the central coast of California. The company primarily offers its banking services under Santa Barbara Bank & Trust, First National Bank of Central California, South Valley National Bank, San Benito Bank, and First Bank of San Luis Obispo brand names. It offers a range of deposit products, including NOW accounts, money market deposit accounts, savings accounts, time certificates of deposit, interest bearing deposits, and demand deposits. The company also provides various loans comprising real estate loans, such as residentiala"one to four family, multi-family residential, commercial, and construction; home equity loans; consumer loans; leases; and demand deposit overdraft protection products, as well as commercial, industrial, and agricultural loans. In addition, it offers safe deposit boxes, travelersa� checks, money orders, foreign exchange services, and cashiers checks. Further, the company provides trust and investment advisory services, as well as a range of wealth management services. As of December 31, 2008, it operated 51 retail branches and 17 loan production offices. The company was founded in 1960 and is based in Santa Barbara, California.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net